Cambridge Molecular Diagnostics Overview

  • Founded
  • 2015

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Cambridge Molecular Diagnostics General Information


Developer of a medical technology designed to build self-contained diagnostic devices. The company's medical technology named Cascade Amplification Technology in integrated with a specific and rapid signal amplification with a molecular cascade and lateral flow approach which helps to perform diagnostics for genetic and molecular targets, enabling medical professionals to diagnose genetic diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Mill House, 37 Mill Lane
  • Stetchworth
  • Cambridgeshire CB8 9TR
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambridge Molecular Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Dec-2017 Completed Out of Business
1. Accelerator/Incubator Completed Startup
To view Cambridge Molecular Diagnostics’s complete valuation and funding history, request access »

Cambridge Molecular Diagnostics Patents

Cambridge Molecular Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202103321-D0 Multiply labelled polymeric constructs for detection assays Pending 10-Mar-2021 000000000000
EP-4025912-A1 Multiply labelled protein for detection assays Pending 06-Sep-2019 0000000000
GB-201912866-D0 Miltiply labelled polymetric molecule for detection assays Inactive 06-Sep-2019
GB-201800861-D0 Nucleic acid amplification and detection assays Active 19-Jun-2015 0000000000
GB-201510850-D0 Nucleic acid amplification and detection assays Inactive 19-Jun-2015 C12Q1/6823
To view Cambridge Molecular Diagnostics’s complete patent history, request access »